Skip to main navigation Skip to search Skip to main content

Munc13-4–STX7 inhibitors impair endosomal TLR activation and systemic inflammation

  • Jennifer L. Johnson
  • , Elsa Meneses-Salas
  • , Aparna Shukla
  • , Binchu Shaji
  • , Farhana Rahman
  • , Jing He
  • , Evripidis Gavathiotis
  • , Steve Brown
  • , Rosana Gonzalez-Quintial
  • , Hal M. Hoffman
  • , Kristi L. Marquardt
  • , John Teijaro
  • , Catherine C. Hedrick
  • , Roberto Baccala
  • , Hugh Rosen
  • , Sergio D. Catz

Research output: Contribution to journalArticlepeer-review

Abstract

Endosomal function is essential for pattern recognition receptor signaling, through endosomal Toll-like receptor (TLR) sensing of nonself RNA and DNA. The specific interaction of the calcium sensor Munc13-4 with syntaxin 7 (STX7) regulates endosomal flux and Munc13-4 depletion decreases the systemic inflammatory response to unmethylated DNA. Using high-throughput screening and orthogonal cell-based validation, we identified small-molecule inhibitors of the Munc13-4–STX7 interaction, ENDOtollins (ENDOs). ENDOs inhibit extracellular signal-regulated kinase signaling in neutrophils and interferon (IFN) regulatory factor signaling in plasmacytoid dendritic cells (DCs) in response to endosomal TLR ligands but not to plasma membrane agonists, highlighting specificity for the endocytic pathway. Mechanistically, ENDOs inhibit endolysosomal flux and decrease endolysosomal cargo degradation. Chemical optimization identified ENDO12 as the most potent inhibitor. ENDO12 inhibited primary DC responses to TLR3, TLR7 and TLR9 and reduced CpG-induced systemic inflammation, manifested as decreased levels of the proinflammatory mediators myeloperoxidase, interleukin 6 and IFNγ. Our findings have significant implications for immunodeficiency, inflammation and innate immunity. (Figure presented.)

Original languageEnglish (US)
JournalNature Chemical Biology
DOIs
StateAccepted/In press - 2026

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Munc13-4–STX7 inhibitors impair endosomal TLR activation and systemic inflammation'. Together they form a unique fingerprint.

Cite this